The Global Glucosamine Market is projected to register a CAGR of 3.8% over the forecast period (2020-2025). Glucosamine is a common supplement used for the treatment of knee osteoarthritis.
Key Highlights
- Glucosamine is legally regarded as a dietary supplement in the United States. However, it is a prescribed drug in Europe. Increased sedentary lifestyle among the general population in these regions is increasing the incidence of bone and joint conditions which has propped up the market for bone and joint supplements such as glucosamine.
Key Highlights
- Glucosamine is also being used in combination with other ingredients such as collagen peptides, hyaluronic acid, vitamins, and traditional herbs. The increased health consciousness of consumers is expected to propel the market for glucosamine further during the forecast period.
Key Market Trends
Increased Usage in Bone and Joint Health Supplements
The World Health Organization (WHO) has estimated that almost 22 million individuals in Europe and 14 million in the United States alone will be suffering from osteoporosis. In 2017, it was observed that more than 200 million people suffered from osteoporosis. Bone and Joint Health Supplements target the aging population and the percentage of population above the age of 65 is significantly high in regions such as North America and Europe. Maintaining a healthy lifestyle and preventing age-related bone diseases particularly at an older age is making consumers pay premium prices for these supplements, as they impart health benefits, targeting treatment of a specific segment of the human body. This trend is certainly continuing, with the rise of simpler, cleaner, and free-from label bone and joint health supplements, as an indicator of the increase in the popularity and acceptance of the natural products. The essential properties of glucosamine have encouraged the manufacturers to introduce new products and thus, lead to the overall growth of the glucosamine market. For instance, global wellness and direct sales leader XANGO launched Xango Aeries Marine Collagen Complex, which is a blend of pure hydrolyzed marine collagen peptides with hyaluronic acid, glucosamine, vitamin C, and traditional herbs to promote healthy skin, hair, joints, and bones.
Europe Leading the Global Market
Europe has several factors conducive to the growth of the glucosamine market. The region has the highest number of people living with osteoarthritis. The World Health Organization (WHO) estimates that between 10% to 15% of the population aged 60 years and above have some form of osteoarthritis. Also, the awareness level of the general population towards health and wellness supplements, especially those used for bone and joint health are high. These factors are increasingly driving the market for glucosamine in the region.
Competitive Landscape
The Global Glucosamine Market is fragmented with global companies competing fiercely with local companies to gain market share. The companies active in the market are not only looking for organic growth through product innovations and geographical expansion, but are also on the lookout for opportunistic acquistions.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
This product will be delivered within 2 business days.
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Koyo Chemical Co., Ltd.
- Schiff Nutrition International Inc.
- Zhejiang Aoxing Biotechnology Co., Ltd.
- Panvo Organics Pvt. Ltd.
- Golden Shell Pharmaceutical Co., Ltd.
- Ethical Naturals, Inc.
- FabriChem, Inc.
Methodology
LOADING...